To gain preliminary data on kratom’s effects in humans, the U.S. Food and Drug Administration (FDA) commissioned a dose-ranging and safety study.

The study showed that controlled servings of dried leaf kratom saw no adverse events and generally positive feelings.

Plus, explore the latest pilot study on the effects of its pharmacodynamic and pharmacokinetic profiles among recreational users with opioid experience.

See the results of both studies here: